
TRAW
Healthcare · Biotechnology · $3.9M market cap
$0.2510-0.03 (-11.9%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +68.3% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | -0.21 | — | — |
| Aug 14, 2026 | After the close | -0.22 | -0.16 | +27.3% |
| May 15, 2026 | Before the open | -0.56 | -0.52 | +7.1% |
| Nov 13, 2025 | Before the open | -9.16 | -0.34 | +96.3% |
| Aug 14, 2025 | Before the open | -8.75 | -0.16 | +98.2% |
| May 15, 2025 | Time not confirmed | -0.27 | 2.09 | +888.7% |
| Mar 31, 2025 | Time not confirmed | -0.25 | 26.60 | +10740.0% |
| Nov 14, 2024 | After the close | -6.25 | -8.81 | -41.0% |
| Aug 15, 2024 | Before the open | -6.25 | -121.75 | -1848.0% |
| Apr 1, 2024 | After the close | -6.33 | -5.00 | +21.0% |
| Mar 14, 2024 | After the close | -0.25 | -0.19 | +24.0% |
| Nov 14, 2023 | After the close | -7.25 | -5.75 | +20.7% |
| Aug 10, 2023 | After the close | -7.81 |
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in…
| -5.00 |
| +36.0% |
| May 15, 2023 | After the close | -7.44 | -7.00 | +5.9% |
| Mar 16, 2023 | Time not confirmed | -0.26 | -0.26 | 0.0% |
| Nov 14, 2022 | After the close | -5.31 | -6.50 | -22.4% |
| Aug 11, 2022 | After the close | -4.94 | -4.75 | +3.8% |
| May 11, 2022 | After the close | -4.69 | -5.00 | -6.6% |
| Mar 17, 2022 | Time not confirmed | -0.17 | -0.17 | 0.0% |
| Nov 11, 2021 | After the close | -8.17 | -5.50 | +32.7% |
| Aug 12, 2021 | After the close | -7.12 | -6.75 | +5.2% |
| May 17, 2021 | Time not confirmed | -0.45 | -0.30 | +33.3% |
| Mar 11, 2021 | After the close | -13.12 | -11.25 | +14.3% |
| Nov 12, 2020 | After the close | -12.50 | -11.25 | +10.0% |
| Aug 12, 2020 | After the close | -11.25 | -15.00 | -33.3% |
| May 14, 2020 | After the close | -20.62 | -11.25 | +45.4% |
| Mar 24, 2020 | Time not confirmed | -0.07 | 1.15 | +1742.9% |
| Nov 12, 2019 | After the close | -255.00 | -281.25 | -10.3% |
| Aug 14, 2019 | Before the open | -330.00 | -225.00 | +31.8% |
| May 14, 2019 | Before the open | -388.12 | -483.75 | -24.6% |
| Mar 26, 2019 | Time not confirmed | -0.97 | -0.98 | -1.0% |
| Nov 13, 2018 | Before the open | -435.00 | -352.50 | +19.0% |
| Aug 14, 2018 | Before the open | -431.25 | -393.75 | +8.7% |
| May 15, 2018 | Time not confirmed | -0.39 | -5.10 | -1207.7% |
| Mar 8, 2018 | Before the open | -3867.19 | -3318.75 | +14.2% |